Analyze Diet
Acta neuropathologica1995; 90(3); 266-272; doi: 10.1007/BF00296510

Endothelial lipopigment as an indicator of alpha-tocopherol deficiency in two equine neurodegenerative diseases.

Abstract: Two spontaneous neurodegenerative diseases of the horse, equine motor neuron disease (EMND) and equine degenerative myeloencephalopathy (EDM), have been associated with alpha-tocopherol deficiency, and both were characterized by prominent accumulations of endothelial lipopigment in the small vessels of the spinal cord. These endothelial pigment deposits appear to be reversible. In EMND horses pasture-supplemented for 9 months or more after the progression of weakness and wasting had arrested, there was very little endothelial lipopigment. The origin and the potential effects of these endothelial lipopigment accumulations are discussed.
Publication Date: 1995-01-01 PubMed ID: 8525800DOI: 10.1007/BF00296510Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the correlation between alpha-tocopherol deficiency and two spinal decompression illnesses in horses, and suggests that the accumulation of endothelial lipopigment might be a major symptom or possible cause.

Objective and Methodology

  • The researchers examined two specific neurodegenerative diseases in horses – equine motor neuron disease (EMND) and equine degenerative myeloencephalopathy (EDM).
  • The focus was on the significant buildup of endothelial lipopigment in the small blood vessels of the horse’s spinal cord.
  • This study considers the hypothesis that these diseases are tied to a deficiency in alpha-tocopherol, a type of Vitamin E.
  • They also studied whether these lipopigment deposits are reversible, particularly in instances where horses with EMND had been pasture-supplemented for nine or more months, post the halt in the progression of weakness and muscle wastage.

Findings and Observations

  • The endothelial pigment deposits tended to be largely reversible, as witnessed in horses with EMND who had been under pasture supplement for 9 months or more, once the progression of muscle wastage and weakness ceased.
  • There was very little endothelial lipopigment in these horses, suggesting a possible correlation between alpha-tocopherol levels and the quantity of endothelial lipopigment.
  • These findings hint at the role that alpha-tocopherol – or its deficiency – might play in causing, or at the very least, influencing the two discussed neurodegenerative diseases in horses.

Discussion of Potential Effects

  • The study brings about the discussion of the origins and the potential effects of endothelial lipopigment accumulations.
  • A clear understanding of this can help in creating nutritional management strategies to prevent or control neurodegenerative diseases in horses.
  • More extensive research is needed to conclusively prove the correlation and understand the exact effects of these endothelial lipopigment accumulations.

Cite This Article

APA
Cummings JF, de Lahunta A, Mohammed HO, Divers TJ, Summers BA, Valentine BA, Jackson CA. (1995). Endothelial lipopigment as an indicator of alpha-tocopherol deficiency in two equine neurodegenerative diseases. Acta Neuropathol, 90(3), 266-272. https://doi.org/10.1007/BF00296510

Publication

ISSN: 0001-6322
NlmUniqueID: 0412041
Country: Germany
Language: English
Volume: 90
Issue: 3
Pages: 266-272

Researcher Affiliations

Cummings, J F
  • Department of Anatomy, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401, USA.
de Lahunta, A
    Mohammed, H O
      Divers, T J
        Summers, B A
          Valentine, B A
            Jackson, C A

              MeSH Terms

              • Animals
              • Encephalomyelitis, Equine / pathology
              • Endothelium / pathology
              • Horses
              • Lipids
              • Motor Neuron Disease / pathology
              • Nerve Degeneration
              • Pigments, Biological / metabolism
              • Spinal Cord / pathology
              • Vitamin E / metabolism

              Grant Funding

              • 1R29NS2967-01AL / NINDS NIH HHS

              References

              This article includes 29 references
              1. Am J Vet Res. 1991 Jun;52(6):908-11
                pubmed: 1883094
              2. Vet Pathol. 1994 Jan;31(1):130-8
                pubmed: 8140721
              3. Science. 1993 Aug 20;261(5124):1047-51
                pubmed: 8351519
              4. Neurology. 1993 May;43(5):966-71
                pubmed: 8492954
              5. Cornell Vet. 1990 Oct;80(4):357-79
                pubmed: 2209016
              6. Vet Pathol. 1974;11(1):68-78
                pubmed: 4432358
              7. Cornell Vet. 1978 Jan;68 Suppl 6:1-207
                pubmed: 618720
              8. J Anat. 1993 Dec;183 ( Pt 3):451-61
                pubmed: 8300427
              9. Am J Respir Cell Mol Biol. 1993 Dec;9(6):603-9
                pubmed: 8257592
              10. Vet Clin North Am Equine Pract. 1987 Aug;3(2):379-83
                pubmed: 3304570
              11. Equine Vet J. 1994 Sep;26(5):409-15
                pubmed: 7988544
              12. Science. 1993 Oct 29;262(5134):689-95
                pubmed: 7901908
              13. Ciba Found Symp. 1983;101:92-105
                pubmed: 6557909
              14. Acta Neuropathol. 1993;85(3):291-7
                pubmed: 8384774
              15. Crit Rev Neurobiol. 1990;5(3):239-63
                pubmed: 2204484
              16. Science. 1994 Jun 17;264(5166):1772-5
                pubmed: 8209258
              17. J Neuropathol Exp Neurol. 1973 Jul;32(3):474-83
                pubmed: 4724827
              18. Brain Res. 1994 Oct 3;659(1-2):272-6
                pubmed: 7820674
              19. J Neurocytol. 1993 Sep;22(9):779-91
                pubmed: 8270961
              20. N Engl J Med. 1991 May 16;324(20):1381-4
                pubmed: 2020294
              21. Ann Neurol. 1977 May;1(5):409-17
                pubmed: 617259
              22. J Vet Intern Med. 1987 Jan-Mar;1(1):45-50
                pubmed: 3506620
              23. J Neuropathol Exp Neurol. 1964 Jan;23:60-77
                pubmed: 14105310
              24. J Neurochem. 1993 Dec;61(6):2322-5
                pubmed: 8245985
              25. Am J Med Genet. 1992 Feb 15;42(4):561-7
                pubmed: 1535179
              26. J Am Vet Med Assoc. 1983 Dec 1;183(11):1266-8
                pubmed: 6643241
              27. J Am Vet Med Assoc. 1977 Jan 15;170(2):195-201
                pubmed: 833044
              28. QJM. 1994 Aug;87(8):445-53
                pubmed: 7922298
              29. J Neuropathol Exp Neurol. 1981 Mar;40(2):166-86
                pubmed: 7463101